No. |
GO terms |
Targets |
# of targets |
p-value (EPT)↑ |
p-value (EPD) |
1 |
low voltage-gated calcium channel activity |
CACNA1H;CACNA1I;CACNA1G |
3 |
1.4E-5 |
0.02 |
2 |
cannabinoid receptor activity |
CNR1;GPR55;CNR2 |
3 |
1.4E-5 |
0.02 |
3 |
calcium channel activity |
TRPM8;TRPV3;TRPV2;TRPV1;TRPV4 |
5 |
2.1E-5 |
0.037 |
4 |
extracellular-glycine-gated chloride channel activity |
GLRA3;GLRB;GLRA1 |
3 |
4.2E-5 |
0.019 |
5 |
drug binding |
CNR1;CHRNA7;GLRB;PPARG;HTR2A |
5 |
0.0022 |
0.19 |
6 |
glycine binding |
GLRA3;GLRB;GLRA1 |
3 |
0.0022 |
0.031 |
7 |
transmitter-gated ion channel activity |
GLRA1;GLRA3 |
2 |
0.0023 |
0.02 |
8 |
G-protein coupled receptor activity |
GPR55;GPR12;GPR18;OPRM1 |
4 |
0.0046 |
0.061 |
9 |
cation channel activity |
TRPV2;TRPV4 |
2 |
0.0058 |
0.018 |
10 |
neuropeptide binding |
OPRD1;OPRM1 |
2 |
0.018 |
0.039 |
11 |
morphine receptor activity |
OPRM1 |
1 |
0.032 |
0.031 |
12 |
serotonin receptor activity |
HTR1A;HTR2A |
2 |
0.032 |
0.052 |
13 |
temperature-gated cation channel activity |
TRPA1 |
1 |
0.032 |
0.016 |
14 |
enkephalin receptor activity |
OPRD1 |
1 |
0.034 |
0.025 |
15 |
stretch-activated, cation-selective, calcium channel activity |
TRPV4 |
1 |
0.036 |
0.021 |
16 |
taurine binding |
GLRA1 |
1 |
0.038 |
0.02 |
17 |
excitatory extracellular ligand-gated ion channel activity |
TRPV1 |
1 |
0.041 |
0.021 |
18 |
prostaglandin receptor activity |
PPARG |
1 |
0.043 |
0.031 |
19 |
voltage-gated calcium channel activity |
CACNA1I;OPRM1 |
2 |
0.046 |
0.039 |
20 |
osmosensor activity |
TRPV4 |
1 |
0.046 |
0.021 |
21 |
beta-endorphin receptor activity |
OPRM1 |
1 |
0.05 |
0.031 |
22 |
acetylcholine-gated cation channel activity |
CHRNA7 |
1 |
0.052 |
0.025 |
23 |
1-(4-iodo-2,5-dimethoxyphenyl)propan-2-amine binding |
HTR2A |
1 |
0.052 |
0.039 |
24 |
scaffold protein binding |
CACNA1H;CACNA1G |
2 |
0.053 |
0.052 |
25 |
ion transmembrane transporter activity |
TRPV2 |
1 |
0.054 |
0.016 |
26 |
G-protein beta-subunit binding |
OPRM1 |
1 |
0.054 |
0.03 |
27 |
extracellular-glycine-gated ion channel activity |
GLRB |
1 |
0.054 |
0.018 |
28 |
voltage-gated anion channel activity |
VDAC1 |
1 |
0.055 |
0.019 |
29 |
beta-tubulin binding |
TRPV4 |
1 |
0.057 |
0.017 |
30 |
chloride channel regulator activity |
CHRNA7 |
1 |
0.059 |
0.025 |
31 |
G-protein alpha-subunit binding |
OPRM1 |
1 |
0.06 |
0.035 |
32 |
porin activity |
VDAC1 |
1 |
0.062 |
0.021 |
33 |
retinoid X receptor binding |
PPARG |
1 |
0.064 |
0.035 |
34 |
RNA polymerase II regulatory region DNA binding |
PPARG |
1 |
0.067 |
0.032 |
35 |
calcium-release channel activity |
TRPV1 |
1 |
0.068 |
0.022 |
36 |
arachidonic acid binding |
PPARG |
1 |
0.068 |
0.032 |
37 |
intracellular ligand-gated calcium channel activity |
TRPA1 |
1 |
0.069 |
0.018 |
38 |
opioid receptor activity |
OPRD1 |
1 |
0.072 |
0.032 |
39 |
channel activity |
TRPA1 |
1 |
0.082 |
0.018 |
40 |
alpha-tubulin binding |
TRPV4 |
1 |
0.087 |
0.02 |
41 |
toxic substance binding |
CHRNA7 |
1 |
0.087 |
0.031 |
42 |
alpha-actinin binding |
PPARG |
1 |
0.089 |
0.039 |
43 |
ion channel activity |
TRPV2 |
1 |
0.091 |
0.023 |
44 |
activating transcription factor binding |
PPARG |
1 |
0.093 |
0.032 |
45 |
SH2 domain binding |
TRPV4 |
1 |
0.099 |
0.031 |
46 |
beta-amyloid binding |
CHRNA7 |
1 |
0.11 |
0.041 |
47 |
ligand-dependent nuclear receptor transcription coactivator activity |
PPARG |
1 |
0.11 |
0.039 |
48 |
serotonin binding |
HTR2A |
1 |
0.12 |
0.052 |
49 |
phosphoprotein binding |
TRPV1 |
1 |
0.12 |
0.032 |
50 |
phosphatidylcholine binding |
GPR12 |
1 |
0.12 |
0.021 |
51 |
transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding |
PPARG |
1 |
0.13 |
0.044 |
52 |
acetylcholine receptor activity |
CHRNA7 |
1 |
0.13 |
0.031 |
53 |
core promoter sequence-specific DNA binding |
PPARG |
1 |
0.14 |
0.058 |
54 |
actin filament binding |
TRPV4 |
1 |
0.15 |
0.036 |
55 |
acetylcholine binding |
CHRNA7 |
1 |
0.16 |
0.052 |
56 |
acetylcholine-activated cation-selective channel activity |
CHRNA7 |
1 |
0.17 |
0.032 |
57 |
protein kinase C binding |
TRPV4 |
1 |
0.17 |
0.032 |
58 |
microtubule binding |
TRPV4 |
1 |
0.21 |
0.031 |
59 |
protein kinase binding |
VDAC1;TRPV4 |
2 |
0.24 |
0.094 |
60 |
RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding |
PPARG |
1 |
0.25 |
0.081 |
61 |
actin binding |
TRPV4 |
1 |
0.25 |
0.03 |
62 |
transcription regulatory region DNA binding |
PPARG |
1 |
0.25 |
0.057 |
63 |
transmembrane signaling receptor activity |
TRPV1 |
1 |
0.27 |
0.048 |
64 |
virus receptor activity |
HTR2A |
1 |
0.27 |
0.053 |
65 |
ion channel binding |
VDAC1 |
1 |
0.29 |
0.057 |
66 |
steroid hormone receptor activity |
PPARG |
1 |
0.29 |
0.096 |
67 |
calmodulin binding |
TRPV4 |
1 |
0.32 |
0.039 |
68 |
transcription factor activity, sequence-specific DNA binding |
PPARG |
1 |
0.43 |
0.11 |
69 |
chromatin binding |
PPARG |
1 |
0.44 |
0.097 |
70 |
DNA binding |
PPARG |
1 |
0.57 |
0.12 |
71 |
enzyme binding |
PPARG |
1 |
0.66 |
0.19 |
72 |
identical protein binding |
TRPV4 |
1 |
0.83 |
0.18 |
73 |
protein homodimerization activity |
CHRNA7 |
1 |
0.85 |
0.17 |
74 |
zinc ion binding |
PPARG |
1 |
0.85 |
0.21 |
75 |
metal ion binding |
CACNA1H |
1 |
0.95 |
0.2 |
76 |
ATP binding |
TRPV4;TRPV1 |
2 |
0.97 |
0.24 |